AGI AGI

TIDMAGI

RNS Number : 9352X

AGI Therapeutics plc

22 February 2012

AGI Therapeutics plc ('AGI')

Holding in Company

AGI was notified on 22 February 2012 that as of 16 February 2012 Aravis Therapeutics Limited has a shareholding of 60,784,191 ordinary shares of EUR0.10 each representing 90.17 per cent of AGI's entire issued share capital.

Contact Information

AGI Therapeutics

   David G. Kelly, Chief Financial Officer   Tel: +353 1 449 3254 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUUSNRUVAUUAR

AGI (LSE:AGI)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024

AGI (LSE:AGI)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024